FindTrial
Sign In

Study showing effectiveness of Nalbuphine as an adjuvant to Bupivacaine in supraclavicular brachial plexus block.

Comparison between Bupivacaine v/s Bupivacaine plus Nalbuphine in supraclavicular brachial plexus block: Double blind randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038423
Enrollment
60
Registered
2021-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Inj Nalbuphine as an adjuvant to Bupivacaine in supraclavicular brachial plexus block.: Adding 1 ml of Nalbuphine to 29 ml of bupivacaine(0.375%). Giving the injection in supraclaviclul

Sponsors

GOVERNMENT MEDICAL COLLEGEBHAVNAGAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)American Society of Anesthesiologists (ASA) physical status I to II of either gender 2) Age: 18â??58 years 3) Patients scheduled for elective forearm and hand surgeries in orthopaedic operation theaters.

Exclusion criteria

Exclusion criteria: 1) Patients with clinically significant coagulopathy 2) Infection at the injection site 3) Allergy to local anesthetics 4) Refusal to technique 5) Patients taking psychotropic medications

Design outcomes

Primary

MeasureTime frame
To Compare effect of Inj Nalbuphine as an adjuvant to Inj Bupivacaine against Inj Bupivacaine alone in terms of 1. The onset of sensory and motor blockade. 2. Duration of sensory and motor blockade. 3. Duration of analgesia (first request for analgesic)Timepoint: 24 hrs—

Secondary

MeasureTime frame
To assess the hemodynamic parameters in two groups in terms of 1. Change in Blood pressure (BP). 2. Change in Respiratory rate. 3. Change in Oxygen saturation (SpO2).Timepoint: 24 hrs—

Countries

India

Contacts

Public ContactDr Komal Shah

GOVERNMENT MEDICAL COLLEGE, BHAVNAGAR

shah.komal@rediffmail.com9427215252

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026